Teleflex | TFX - Current Liabilities


Teleflex reported $762.03M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Align Technology USD 1.92B 46.45M Dec/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
AtriCure USD 81.52M 3.68M Dec/2025
Avanos Medical USD 165.2M 17.3M Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
Cooper Companies USD 1.6B 482.9M Dec/2025
Dexcom USD 2.14B 1.19B Dec/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
General Electric Aerospace USD 38.98B 1.78B Dec/2025
Globus Medical USD 498.5M 32.54M Dec/2025
Haemonetics USD 539.87M 8.45M Dec/2025
Hologic USD 951.3M 25.9M Dec/2025
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 455.98M 91.93M Dec/2025
Intuitive Surgical USD 2.52B 207.3M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Masimo USD 371.6M 1.9M Dec/2025
Medtronic USD 9.5B 440M Dec/2025
Merit Medical Systems USD 239.76M 9.29M Dec/2025
Orthofix International USD 170.48M 10.64M Dec/2025
ResMed USD 1.25B 7.39M Dec/2025
Steris USD 922.3M 33.4M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 762.03M 11.01M Dec/2025
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025